Has registered another drug for the treatment COVID-19. Registration certificate received the drug Levelmap (trade name Elsira). On Saturday, June 6, RIA Novosti reported with reference to the press service of the Ministry of health.
“The drug is indicated for patients with severe disease develops when the so-called cytokine storm – an excessive inflammatory reaction to the introduction of the virus, which causes damage to tissues and organs, in particular lung tissue, to a severe course of the infection with a possible lethal outcome”, – stated in the message.
It is noted that Levelmap produces biotechnological company Biocad. This Russian is an inhibitor of interleukin-6. As follows from the temporary methodical recommendations of the Ministry of health for the prevention, diagnosis and treatment coronavirus infection, the mortality rate is COVID-19 is associated with increased levels of interleukin-6. Initially the drug was developed to treat rheumatoid arthritis.